Association between Body Composition and the Risk of Portopulmonary Hypertension Assessed by Computed Tomography in Patients with Liver Cirrhosis

被引:0
作者
Miwa, Takao [1 ,2 ]
Hanai, Tatsunori [1 ,3 ]
Nishimura, Kayoko [3 ]
Tajirika, Satoko [1 ,2 ]
Nakahata, Yuki [1 ,4 ]
Imai, Kenji [1 ]
Suetsugu, Atsushi [1 ]
Takai, Koji [1 ,5 ]
Yamamoto, Mayumi [2 ,6 ]
Shimizu, Masahito [1 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu 5011194, Japan
[2] Gifu Univ, Hlth Adm Ctr, Gifu 5011193, Japan
[3] Gifu Univ Hosp, Ctr Nutr Support & Infect Control, Gifu 5011194, Japan
[4] Asahi Univ Hosp, Dept Gastroenterol, Gifu 5011194, Japan
[5] Gifu Univ, Grad Sch Med, Div Reg Canc Control, Gifu 5011194, Japan
[6] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan
关键词
adipose tissue; muscle; obesity; pulmonary hypertension; sarcopenia; sarcopenic obesity; MAYO-CLINIC EXPERIENCE; PRACTICE GUIDELINES; WORKING GROUP; SARCOPENIA; DIAGNOSIS; PREVALENCE; SURVIVAL; SOCIETY;
D O I
10.3390/jcm12103351
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to investigate the impact of body composition on the risk of portopulmonary hypertension using computed tomography (CT) in patients with liver cirrhosis. We retrospectively included 148 patients with cirrhosis treated at our hospital between March 2012 and December 2020. POPH high-risk was defined as main pulmonary artery diameter (mPA-D) = 29 mm or mPA-D to ascending aorta diameter ratio = 1.0, based on chest CT. Body composition was assessed using CT images of the third lumbar vertebra. The factors associated with POPH high-risk were evaluated using logistic regression and decision tree analyses, respectively. Among the 148 patients, 50% were females, and 31% were found to be high-risk cases on evaluation of chest CT images. Patients with a body mass index (BMI) of = 25 mg/m(2) had a significantly higher prevalence of POPH high-risk than those with a BMI < 25 mg/m(2) (47% vs. 25%, p = 0.019). After adjusting for confounding factors, BMI (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.10-1.33), subcutaneous adipose tissue index (OR, 1.02; 95% CI, 1.01-1.03), and visceral adipose tissue index (OR, 1.03; 95% CI, 1.01-1.04) were associated with POPH high-risk, respectively. In the decision tree analysis, the strongest classifier of POPH high-risk was BMI, followed by the skeletal muscle index. Body composition may affect the risk of POPH based on chest CT assessment in patients with cirrhosis. Since the present study lacked data on right heart catheterization, further studies are required to confirm the results of our study.
引用
收藏
页数:13
相关论文
共 32 条
[1]   Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization [J].
Atsukawa, Masanori ;
Tsubota, Akihito ;
Hatano, Masaru ;
Kondo, Chisa ;
Shioda, Kaori ;
Ohno, Hiroki ;
Kawano, Tadamichi ;
Hayama, Korenobu ;
Arai, Taeang ;
Nakagawa-Iwashita, Ai ;
Itokawa, Norio ;
Kaneko, Keiko ;
Yoshida, Yuji ;
Koeda, Mai ;
Okubo, Tomomi ;
Yamamoto, Teppei ;
Yamamoto, Takeshi ;
Taniai, Nobuhiko ;
Yoshida, Hiroshi ;
Kanazawa, Hidenori ;
Shimizu, Wataru ;
Iwakiri, Katsuhiko .
HEPATOLOGY RESEARCH, 2020, 50 (11) :1244-1254
[2]   Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment [J].
Chen, Liang-Kung ;
Woo, Jean ;
Assantachai, Prasert ;
Auyeung, Tung-Wai ;
Chou, Ming-Yueh ;
Iijima, Katsuya ;
Jang, Hak Chul ;
Kang, Lin ;
Kim, Miji ;
Kim, Sunyoung ;
Kojima, Taro ;
Kuzuya, Masafumi ;
Lee, Jenny S. W. ;
Lee, Sang Yoon ;
Lee, Wei-Ju ;
Lee, Yunhwan ;
Liang, Chih-Kuang ;
Lim, Jae-Young ;
Lim, Wee Shiong ;
Peng, Li-Ning ;
Sugimoto, Ken ;
Tanaka, Tomoki ;
Won, Chang Won ;
Yamada, Minoru ;
Zhang, Teimei ;
Akishita, Masahiro ;
Arai, Hidenori .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) :300-+
[3]   The Myths and Realities of Portopulmonary Hypertension [J].
DuBrock, Hilary M. ;
Krowka, Michael J. .
HEPATOLOGY, 2020, 72 (04) :1455-1460
[4]   Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension [J].
DuBrock, Hilary M. ;
Rodriguez-Lopez, Josanna M. ;
LeVarge, Barbara L. ;
Curry, Michael P. ;
VanderLaan, Paul A. ;
Zsengeller, Zsuzsanna K. ;
Pernicone, Elizabeth ;
Preston, Ioana R. ;
Yu, Paul B. ;
Nikolic, Ivana ;
Xu, Dihua ;
Thadhani, Ravi I. ;
Channick, Richard N. ;
Karumanchi, S. Ananth .
PULMONARY CIRCULATION, 2016, 6 (04) :498-507
[5]   Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis [J].
Ebadi, Maryam ;
Tandon, Puneeta ;
Moctezuma-Velazquez, Carlos ;
Ghosh, Sunita ;
Baracos, Vickie E. ;
Mazurak, Vera C. ;
Montano-Loza, Aldo J. .
JOURNAL OF HEPATOLOGY, 2018, 69 (03) :608-616
[6]   Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes [J].
Frank, Rachel C. ;
Min, Jeff ;
Abdelghany, Mazin ;
Paniagua, Samantha ;
Bhattacharya, Romit ;
Bhambhani, Vijeta ;
Pomerantsev, Eugene ;
Ho, Jennifer E. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05)
[7]   2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) [J].
Galie, Nazzareno ;
Humbert, Marc ;
Vachiery, Jean-Luc ;
Gibbs, Simon ;
Lang, Irene ;
Torbicki, Adam ;
Simonneau, Gerald ;
Peacock, Andrew ;
Noordegraaf, Anton Vonk ;
Beghetti, Maurice ;
Ghofrani, Ardeschir ;
Gomez Sanchez, Miguel Angel ;
Hansmann, Georg ;
Klepetko, Walter ;
Lancellotti, Patrizio ;
Matucci, Marco ;
McDonagh, Theresa ;
Pierard, Luc A. ;
Trindade, Pedro T. ;
Zompatori, Maurizio ;
Hoeper, Marius .
EUROPEAN HEART JOURNAL, 2016, 37 (01) :67-+
[8]   Sarcopenia impairs prognosis of patients with liver cirrhosis [J].
Hanai, Tatsunori ;
Shiraki, Makoto ;
Nishimura, Kayoko ;
Ohnishi, Sachiyo ;
Imai, Kenji ;
Suetsugu, Atsushi ;
Takai, Koji ;
Shimizu, Masahito ;
Moriwaki, Hisataka .
NUTRITION, 2015, 31 (01) :193-199
[9]   A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade [J].
Hiraoka, Atsushi ;
Kumada, Takashi ;
Hirooka, Masashi ;
Tsuji, Kunihiko ;
Itobayashi, Ei ;
Kariyama, Kazuya ;
Ishikawa, Toru ;
Tajiri, Kazuto ;
Ochi, Hirofumi ;
Tada, Toshifumi ;
Toyoda, Hidenori ;
Nouso, Kazuhiro ;
Joko, Koji ;
Kawasaki, Hideki ;
Hiasa, Yoichi ;
Michitaka, Kojiro .
HEPATOLOGY RESEARCH, 2018, 48 (03) :E61-E67
[10]  
Humbert M, 2022, Eur Heart J, DOI DOI 10.1183/13993003.00879-2022